The Senate yesterday voted 57-42 to approve President Trump’s nomination of Scott Gottlieb, M.D., as commissioner of the Food and Drug Administration. Gottlieb most recently was a resident fellow at the American Enterprise Institute and venture partner at New Enterprise Associates. He previously served as FDA deputy commissioner for medical and scientific affairs under President George W. Bush.